Clinical Trial Update: VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2 [Phase 2]

View source ↗

Summary

Phase 2 trial of VGX-3100 delivered intramuscularly with electroporation for HPV-16/18 associated HSIL in HIV-seronegative individuals; study completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Neoplasm
• High-grade Squamous Intraepithelial Lesion

Drugs mentioned

• VGX-3100

Snippet

Sponsor: Inovio Pharmaceuticals | Conditions: Anal Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2023-07-03